novo nordisk lawsuits against compounding pharmacies semaglutide 2023 2024 2025 A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Hims & Hers Health and

Those who suffer from Imerslund-Grasbeck disease , a genetic disorder, are unable to absorb dietary B12

26 Certain GLP-1 agonist drugs have been associated with a significantly increased risk of depression and anxiety, 27 highlighting an emerging need for complimentary therapies to support patients mental and emotional health while undergoing pharmaceutical GLP-1 therapy

Glutathione, being a powerful antioxidant, has wondrous skin brightening benefits

They modified the structure of small opioid neuropeptides that possessed very weak GH-releasing activity, assuming that structural alteration might produce new peptides with greater efficacy